We are a venture capital firm that helps fearless founders tackle hard problems with capital, resources and collaboration. We are based in San Francisco, Paris and Tokyo.
Employees: 1-10
Investment Type: Venture Capital
Investment Stage: Seed
Portfolio 53
| Date | Name | Website | Total Raised | Location |
| 15.07.2025 | Karavela | karavela.ai | - | - |
| 26.06.2025 | Lendurai | lendurai.com | $6.37M | - |
| 26.06.2025 | Kyron.Bio | kyron.bio | $6.26M | - |
| 27.04.2025 | Navier | navier.ai | $5.6M | United Sta... |
| 22.04.2025 | Cosmic Rob... | cosmicrobotics.com | $4M | - |
| 08.04.2025 | Dyna | dyna.co | $143.5M | - |
| 08.04.2025 | Delian | delian.ai | - | - |
| 08.04.2025 | Fuse Vecto... | fusevectors.com | $5.2M | Denmark, C... |
| 08.04.2025 | Karman+ | karmanplus.com | - | - |
| 15.09.2024 | QUiCKR Bio | quickrbio.com | - | - |
Show more
Mentions in press and media 18
| Date | Title | Description |
| 06.02.2026 | Chiral raises $12M to unlock post-silicon computing beyond Moore’s Law | As the semiconductor industry approaches the physical and economic limits of silicon scaling described by Moore’s Law, nanomaterials such as carbon nanotube and two-dimensional materials are widely seen as a viable path to sustain performa... |
| 29.07.2025 | Greek defence tech startup founded by Apple roboticist raises $14M | A Greek defence tech startup founded by a former Apple roboticist has raised $14m in a Series A funding round. Athens-based Delian Alliance Industries is developing autonomous weapons, including drones and surveillance towers equipped with ... |
| 29.05.2025 | Kyron.bio: Pioneering a New Era in Antibody Therapeutics | In the bustling world of biotechnology, a new player is making waves. Kyron.bio, a Paris-based startup, has secured €5.5 million in seed funding to revolutionize drug development. This funding is not just a financial boost; it’s a lifeline ... |
| 28.05.2025 | Kyron.bio Secures $6.2M to Optimize Biologic Drug Development with Precision Glycan Engineering | What You Should Know: – Biotechnology company kyron.bio announced the successful closing of a $6.2M (€5.5M) seed funding round aimed at solving critical challenges in biologic drug development, specifically varying efficacy and the dangers ... |
| 28.05.2025 | Paris-based kyron.bio secures €5.5 million to tackle drug efficiency and safety | French BioTech company kyron.bio announced today a €5.5 million Seed funding round to tackle the issues of varying efficacy and dangerous side effects in current drug development, using control of sugar molecules – also known as glycans. Th... |
| 25.02.2025 | Biotech Fuse Vectors secures $5.2M to advance cell-free gene therapy tech | Fuse Vectors has raised $5.2M in pre-seed financing led by HCVC for its cell-free viral vector technology. The funding will accelerate the development of Fuse's technology platform and pipeline of novel gene therapies. Fuse Vectors is a bio... |
| 28.04.2024 | London’s first defense tech hackathon brings Ukraine war closer to the city’s startups | Last week, the U.K. announced its largest ever military support package for Ukraine. The bill brings the U.K.’s total support for this financial year to £3 billion — not quite the $50 billion the U.S. pledged recently, but still substantial... |
| 06.03.2024 | Chiral powers next-generation electronics with nanomaterials as it raises $3.8m | Research has evidenced the use case and impact of nanomaterials across a range of electronics including high-performance transistors, low-power sensors, quantum devices, and many more. However, existing production methods, mostly based on ... |
| 07.02.2024 | Time for kitchen staff to upshift: robots are coming | Chef Robotics seeks to resolve labor shortage in US food prep market We’ve all heard of robots coming to the fast-food chains. McDonald’s has been running its roboticized spot in Texas and Chick-fil-A has been testing robot servers. But a l... |
| 29.01.2024 | Over CHF 20 million for Transmutex novel nuclear energy system | Founded on 29 July 2019, Geneva based Transmutex is reinventing nuclear energy with the design of a safer, non-self-sustaining reaction technology that will usher in a new era of lower-cost and proliferation-resistant, carbon-free baseload... |
Show more